Evidence map›Paper›PMID 26438524›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion.

Yoshie Iizuka, Frank Cichocki, Andrew Sieben, Fabio Sforza, Razaul Karim, Kathleen Coughlin, Rachel Isaksson Vogel, Riccardo Gavioli, Valarie McCullar, Todd Lenvik and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Yoshie IizukaDepartment of Obstetrics, Gynecology and Women's Heath, University of Minnesota Twin Cities, Minneapolis, MN 55455;
Frank CichockiHematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455;
Andrew SiebenDepartment of Obstetrics, Gynecology and Women's Heath, University of Minnesota Twin Cities, Minneapolis, MN 55455;
Fabio SforzaDepartment of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy; and.
Razaul KarimDepartment of Neuroscience, University of Minnesota, Minneapolis, MN 55455.
Kathleen CoughlinDepartment of Obstetrics, Gynecology and Women's Heath, University of Minnesota Twin Cities, Minneapolis, MN 55455;
Rachel Isaksson VogelDepartment of Obstetrics, Gynecology and Women's Heath, University of Minnesota Twin Cities, Minneapolis, MN 55455;
Riccardo GavioliDepartment of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy; and.
Valarie McCullarHematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455;
Todd LenvikHematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455;
Michael LeeDepartment of Neuroscience, University of Minnesota, Minneapolis, MN 55455.
Jeffrey MillerHematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455;
Martina BazzaroDepartment of Obstetrics, Gynecology and Women's Heath, University of Minnesota Twin Cities, Minneapolis, MN 55455; mbazzaro@umn.edu.
Twin Cities Orthopedics · USUniversity of Minnesota · USUniversity of Ferrara · ITMinnesota Oncology · USUniversity of Minnesota Medical Center · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
NCATS NIH HHS UL1 TR002494NCI NIH HHS P30 CA077598
6 · The paper itself

Abstract

NK cell's killing is a tightly regulated process under the control of specific cytoskeletal proteins. This includes Wiskott-Aldrich syndrome protein, Wiskott-Aldrich syndrome protein-interacting protein, cofilin, Munc13-4, and nonmuscle myosin IIA (NMIIA). These proteins play a key role in controlling NK-mediated cytotoxicity either via regulating the attachment of lytic granules to the actin-based cytoskeleton or via promoting the cytoskeletal reorganization that is requisite for lytic granule release. UNC-45A is a highly conserved member of the UNC-45/CRO1/She4p family of proteins that act as chaperones for both conventional and nonconventional myosin. Although we and others have shown that in lower organisms and in mammalian cells NMIIA-associated functions, such as cytokinesis, cell motility, and organelle trafficking, are dependent upon the presence of UNC-45A, its role in NK-mediated functions is largely unknown. In this article, we describe UNC-45A as a key regulator of NK-mediated cell toxicity. Specifically we show that, in human NK cells, UNC-45A localize at the NK cell immunological synapse of activated NK cells and is part of the multiprotein complex formed during NK cell activation. Furthermore, we show that UNC-45A is disposable for NK cell immunological synapse formation and lytic granules reorientation but crucial for lytic granule exocytosis. Lastly, loss of UNC-45A leads to reduced NMIIA binding to actin, suggesting that UNC-45A is a crucial component in regulating human NK cell cytoskeletal dynamics via promoting the formation of actomyosin complexes.

Indexed as

Actin Depolymerizing FactorsActinsBiological Transport, ActiveCell MovementCytoskeletonExocytosisFemaleHumansImmunological SynapsesIntracellular Signaling Peptides and ProteinsKiller Cells, NaturalLymphocyte ActivationMaleMembrane ProteinsNonmuscle Myosin Type IIASecretory VesiclesActin Depolymerizing FactorsActinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsNonmuscle Myosin Type IIAUNC13D protein, humanUNC45A protein, human

Identifiers

PMID26438524
PMCPMC5189640
OpenAlexW2244650649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.